Urogen Pharma (URGN) Investor Presentation - Slideshow

NOVEMBER 2021 UROGEN PHARMA Forward Looking Statements 2 This investor presentation contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation: the potential market opportunity of Jelmyto in LG-UTUC; commercial plans for favorable market access and both patient and physician uptake; expected interest in prescribing Jelmyto; the continued successful launch of Jelmyto; the potential of UroGen's proprietary RTGel™ technolog ...